1:44 PM
 | 
Oct 12, 2017
 |  BC Extra  |  Financial News

Protagonist raises $60M in follow-on

Protagonist Therapeutics Inc. (NASDAQ:PTGX) raised $60 million through the sale of 3.5 million shares at $17 in a follow-on underwritten by Leerink, Barclays, BMO Capital Markets, Stifel, BTIG and Nomura. The price is a 14%...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >